You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.
An international team of researchers put nine immune cell sequencing methods head to head, including RNA-based and DNA-based ones, using the same T-cell sample.
By employing distributed computational resources and a novel algorithm, the VariantSpark technology is able to process a trillion data points in 15 hours.
Labs are finding cheaper, higher-throughput ways to determine the inflection points in gene expression within a particular cell.
Two companies offering droplet-based single-cell RNA sequencing sample prep, 10x Genomics and 1Cellbio, have launched dual-indexed library preparation products.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods.
The firm touts a new hybridization probe design, which it says will enable small, focused panels that reduce sequencing costs and assay time.
Buzzfeed News reports that a paper previously published by the founder of Surgisphere may contain an alleged instance of image manipulation.
The Guardian writes that the retraction last week of two COVID-19 papers may affect public trust in science.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.